Tamar Tsereteli

发表

Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies.

T. Shochet, B. Winikoff, K. Louie, 2019, Contraception.

Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia

B. Winikoff, E. Chong, K. Louie, 2017, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine

B. Winikoff, I. Platais, Tamar Tsereteli, 2019, BMJ Sexual & Reproductive Health.

Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan

B. Winikoff, S. Raghavan, A. Kamilov, 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

The introduction of first trimester medical abortion in Armenia

B. Winikoff, E. Chong, K. Louie, 2014, Reproductive health matters.

Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan

B. Winikoff, I. Platais, G. Grebennikova, 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

B. Winikoff, E. Chong, Tamar Tsereteli, 2009, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.

B. Winikoff, E. Chong, Tamar Tsereteli, 2012, Contraception.

A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.

Milind S. Shah, B. Winikoff, G. Tsertsvadze, 2014, Contraception.

Original research article A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial ☆☆,★,★★

Milind S. Shah, B. Winikoff, G. Tsertsvadze, 2014 .

Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia

B. Winikoff, E. Chong, K. Louie, 2016, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan

B. Winikoff, E. Chong, Gulnara Rzayeva, 2014, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan.

B. Winikoff, I. Platais, R. Comendant, 2015, Contraception.

Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits

N. Tsereteli, G. Tsertsvadze, I. Platais, 2023, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.